Pmtct totals indicator definitions

6.1. TOTALS- PMTCT services in
Total number of HIV positive pregnant women identified in antenatal care:
1.1.3 Number of pregnant women newly enrolled in antenatal care with known HIV status
PLUS
1.1.8 Number of pregnant women with an HIV positive test result in antenatal care
Total number of HIV positive pregnant women who received ARV prophylaxis for PMTCT in
antenatal care
1.2.2 Number of HIV positive pregnant women who received single dose nevirapine in antenatal
care
PLUS
1.2.4 Number of HIV positive pregnant women who received other ARV regimens for PMTCT
in antenatal care
Total number of HIV positive pregnant women initiating ARV treatment in antenatal care
1.2.8 Number of HIV positive pregnant women assessed initiating ARV treatment in antenatal
care
Total number of HIV positive pregnant women identified in labor and delivery
2.1.4 Number of pregnant women arriving in labor and delivery with known positive HIV status
PLUS
2.1.9 Number of pregnant women tested in labor and delivery with a positive HIV test result
Total number of HIV positive pregnant women who received ARV prophylaxis for PMTCT in
labor and delivery
2.2.1 Number of HIV positive pregnant women who received single dose nevirapine at labor and
delivery
PLUS
2.2.3 Number of HIV positive pregnant women who received other ARV regimens for PMTCT
at labor and delivery
Total number of HIV positive pregnant women on ARV treatment in labor and delivery
2.2.7 Number of HIV positive pregnant women on ARV treatment in labor and delivery

6.2. TOTALS- Overall PMTCT program
Total number of pregnant women eligible for counseling and testing
1.1.2 Number of pregnant women newly enrolled in antenatal care
MINUS
1.1.3 Number of pregnant women newly enrolled in antenatal care with known HIV positive
status
PLUS
2.1.5 Number of pregnant women arriving in labor and delivery with unknown HIV status

Total number of pregnant women who received counseling and education
1.1.5 Number of pregnant women who received HIV counseling and education in antenatal care
PLUS
2.1.6 Number of pregnant women who received HIV counseling and education in labor and
delivery
Total number of pregnant women tested for HIV
1.1.6 Number of pregnant women who were tested for HIV in antenatal care
PLUS
2.1.7 Number of pregnant women who were tested for HIV in labor and delivery

Total number of women who received test results
1.1.7 Number of pregnant women who received HIV test results in antenatal care
PLUS
2.1.8 Number of pregnant women tested in labor and delivery who received HIV test results
Total number of HIV positive women identified through PMTCT
1.1.3 Number of pregnant women newly enrolled in antenatal care with known HIV status
PLUS
1.1.8 Number of pregnant women with an HIV positive test result in antenatal care
PLUS
2.1.4 Number of pregnant women arriving in labor and delivery with known positive HIV status
PLUS
2.1.9 Number of pregnant women tested in labor and delivery with a positive HIV test result
Total number of HIV positive women who received only single dose nevirapine
1.2.2 Number of HIV positive pregnant women who received only single dose nevirapine in
antenatal care
PLUS
2.2.1 Number of HIV positive pregnant women who received only single dose nevirapine in
labor and delivery
Total number of HIV exposed infants who received only single dose nevirapine
1.2.3 Number of infant doses of nevirapine distributed to HIV positive pregnant women in
antenatal care
PLUS
2.2.2 Number of HIV exposed infants who received only single dose nevirapine in labor and
delivery
Total number of HIV positive women who received any other ARV prophylaxis
1.2.4 Number of HIV positive pregnant women who received other ARV regimens for PMTCT
at antenatal care
PLUS
2.2.3 Number of HIV positive pregnant women who received other ARV regimens for PMTCT
at labor and delivery
Total number of HIV exposed infants who received any other ARV prophylaxis
1.2.6 Number of infant doses of other ARV regimens distributed to HIV positive pregnant
women in antenatal care
PLUS
2.2.5 Number of HIV exposed infants who received other ARV regimens for PMTCT in labor
and delivery
Total number of HIV positive pregnant women who received ARV prophylaxis
1.2.2 Number of HIV positive pregnant women who received single dose nevirapine in antenatal
care
PLUS
1.2.4 Number of HIV positive pregnant women who received other ARV regimens for PMTCT
in antenatal care
PLUS
2.2.1 Number of HIV positive pregnant women who received single dose nevirapine at labor and
delivery
PLUS
2.2.3 Number of HIV positive pregnant women who received other ARV regimens for PMTCT
at labor and delivery
Total number of HIV exposed infants who received ARV prophylaxis
1.2.3 Number of infant doses of nevirapine distributed to HIV positive pregnant women in
antenatal care
PLUS
2.2.2 Number of HIV exposed infants who received only single dose nevirapine in labor and
delivery
PLUS
1.2.6 Number of infant doses of other ARV regimens distributed to HIV positive pregnant
women in antenatal care
PLUS
2.2.5 Number of HIV exposed infants who received other ARV regimens for PMTCT in labor
and delivery
Total number of HIV positive pregnant women on ARV treatment
1.2.8 Number of HIV positive pregnant women initiating ARV treatment in antenatal care
PLUS
2.2.7 Number of HIV positive pregnant women on ARV treatment in labor and delivery

6.3. Follow up of HIV exposed infants
• Total number of HIV positive mothers initiating breastfeeding • Total number of HIV positive mothers initiating replacement feeding • Total number of HIV exposed infants seen at first immunization visit • Total number of HIV exposed infants who started cotrimoxazole prophylaxis at six • Number of HIV exposed infants seen at • Total number of HIV exposed infants who continued cotrimoxazole prophylaxis at six • Total number of HIV exposed infants breastfed at six months of age • Number of HIV exposed infants weaned at six months of age • Number of HIV exposed infants seen for measles immunization per national guidelines 6.4. Testing of HIV exposed infants
• Number of HIV exposed infants tested for HIV at less than six months of age • Number of HIV exposed infants tested for HIV between six and twelve months of age • Number of HIV exposed infants tested for HIV over twelve months of age and older • Number of HIV positive infants
THERE IS NO SECTION 6.5. WE ARE NOT MISSING ANY INDICATORS, THE
NUMBERING IS WRONG. THIS WILL BE FIXED IN THE FORM AND IN
GLASER


6.6. Screening and staging for HIV illness among individuals identified as HIV positive
through
• Total number of pregnant women (>= 15 years old) identified as HIV positive through PMTCT that were screened or staged for illness • Total number of pregnant girls (< 15 years old) identified as HIV positive through PMTCT that were screened or staged for illness • Total number of non-pregnant women (>= 15 years old) identified as HIV positive through PMTCT that were screened or staged for illness • Total number of adult men (>= 15 years old) identified as HIV positive through PMTCT that were screened or staged for illness • Total number of female children (< 15 years old) identified as HIV positive through PMTCT that were screened or staged for illness • Total number of male children (< 15 years old) identified as HIV positive through PMTCT that were screened or staged for illness 6.7. Enrollment of individuals identified as HIV positive through the PMTCT program into
Care
Treatment
services
• Total number of pregnant women (>= 15 years old) identified as HIV positive through PMTCT that were enrolled into care and treatment • Total number of pregnant girls (< 15 years old) identified as HIV positive through PMTCT that were enrolled into care and treatment • Total number of non-pregnant women (>= 15 years old) identified as HIV positive through PMTCT that were enrolled into care and treatment • Total number of adult men (>= 15 years old) identified as HIV positive through PMTCT that were enrolled into care and treatment • Total number of female children (< 15 years old) identified as HIV positive through PMTCT that were enrolled into care and treatment • Total number of male children (< 15 years old) identified as HIV positive through PMTCT that were enrolled into care and treatment 6.8. Initiation of HAART among individuals identified as HIV positive through the
PMTCT
• Total number of pregnant women (>= 15 years old) identified as HIV positive through • Total number of pregnant girls (< 15 years old) identified as HIV positive through • Total number of non-pregnant women (>= 15 years old) identified as HIV positive through PMTCT that were started on HAART • Total number of adult men (>= 15 years old) identified as HIV positive through PMTCT • Total number of female children (< 15 years old) identified as HIV positive through • Total number of male children (< 15 years old) identified as HIV positive through 6.9. Additional counseling and testing services
• Total number of male partners of pregnant women tested for HIV • Total number of children of pregnant women tested for HIV • Total number of men (>= 15 years old, non-partners) tested for HIV • Total number of non-pregnant women (>= 15 years old) tested for HIV • Total number of children (< 15 years old, not related to pregnant women reached by • Total number of male partners of pregnant women with positive HIV test • Total number of men (>= 15 years old, non-partners) with positive HIV test • Total number of non-pregnant women (>= 15 years old) with positive HIV test • Total number of children (< 15 years old, not related to pregnant women reached by

Source: http://glaser.pedaids.org/EGPAF_Uploads/PMTCT%20Totals%20definitions%20-updated%208.4.08.pdf